Rivaroxaban versus enoxaparin for prophylaxis of venous thromboembolism in morbidly obese patients undergoing bariatric surgery: An open\_label randomized controlled trial
Eligibility
Sex
ALL
Min age
20 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Age: 20-60 years, both sexes.
* ASA physical status class I to III.
* BMI 35-50 kg/m²
Exclusion Criteria:
* Severe cardiac disorder
* chronic renal failure
* liver cirrhosis
* major psychological disorder
Primary outcome measure(s)
Incidence of thromboembolic events — month 3 postoperative deep vein thrombosis, pulmonary thromboembolism, mesenteric vascular occlusion
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.